Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18. (Q45733665)

15 December 2017

Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18. (English)

1 reference

feline immunodeficiency virus

15 December 2017

object named as

feline immunodeficiency virus

1 reference

1

1 reference

15 December 2017

J Norman Flynn

2

1 reference

15 December 2017

Mark A Rigby

3

1 reference

15 December 2017

Julie Macdonald

4

1 reference

15 December 2017

Jennifer Bruce

5

1 reference

15 December 2017

Celia Cannon

6

1 reference

15 December 2017

Matthew C Golder

7

1 reference

15 December 2017

Linda Hanlon

8

1 reference

15 December 2017

David A Harbour

9

1 reference

15 December 2017

Nancy A Mackay

10

1 reference

15 December 2017

Norman Spibey

11

1 reference

15 December 2017

Oswald Jarrett

12

1 reference

15 December 2017

James C Neil

13

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

15 December 2017

1 reference

15 December 2017

20

1 reference

15 December 2017

11-12

1 reference

15 December 2017

1483-1496

1 reference

Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines

15 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Immunopathogenesis of vaccine-enhanced RSV disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

The promise of nucleic acid vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Factors influencing cellular immune responses to feline immunodeficiency virus induced by DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Interleukin-18 modulates immune responses induced by HIV-1 Nef DNA prime/protein boost vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Establishment of a feline T-lymphoblastoid cell line highly sensitive for replication of feline immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Development, characterization, and viral susceptibility of a feline (Felis catus) renal cell line (CRFK).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Rapid feline immunodeficiency virus provirus quantitation by polymerase chain reaction using the TaqMan fluorogenic real-time detection system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Proviral load determination of different feline immunodeficiency virus isolates using real-time polymerase chain reaction: influence of mismatches on quantification.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Accurate estimation of transduction efficiency necessitates a multiplex real-time PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Serological diagnosis of feline immunodeficiency virus infection based on synthetic peptides from Env glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Suppression of feline immunodeficiency virus replication in vitro by a soluble factor secreted by CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Characterization of feline immunodeficiency virus integrase and analysis of functional domains

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Serological responses of cats to feline immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Comparison of serological tests for the diagnosis of feline immunodeficiency virus infection of cats

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Effect of different promoters on immune responses elicited by HIV-1 gag/env multigenic DNA vaccine in Macaca mulatta and Macaca nemestrina

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

The prime-boost strategy: exciting prospects for improved vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1-specific DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL-12 boost are mediate

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

MHC-restricted protection of cats against FIV infection by adoptive transfer of immune cells from FIV-vaccinated donors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Immunization of dogs and cats with a DNA vaccine against rabies virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

Passive antibody protection of cats against feline immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

HIV-1 neutralizing antibodies: how full is the bottle?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900507-2

7 January 2021

10.1016/S0264-410X(01)00507-2

Identifiers

DOI

1 reference

15 December 2017

1 reference